BiotechTube

RG1068 (Synthetic Human Secretin)

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Obsessive Compulsive Disorder (OCD)

Conditions

Obsessive Compulsive Disorder (OCD)

Trial Timeline

Feb 1, 2005 → Apr 1, 2006

NCT ID
NCT00216294

About RG1068 (Synthetic Human Secretin)

RG1068 (Synthetic Human Secretin) is a phase 2 stage product being developed by Repligen for Obsessive Compulsive Disorder (OCD). The current trial status is completed. This product is registered under clinical trial identifier NCT00216294. Target conditions include Obsessive Compulsive Disorder (OCD).

What happened to similar drugs?

5 of 10 similar drugs in Obsessive Compulsive Disorder (OCD) were approved

Approved (5) Terminated (1) Active (4)
✅DuloxetineEli LillyApproved
🔄Fluvoxamine maleate + PlaceboAbbViePhase 3
🔄quetiapine fumarate + SSRI/ClomipramineAstraZenecaPhase 3
✅Clomipramine (fluoxetine plus clomipramine) + Quetiapine (fluoxetine plus quetiapine) + Placebo (fluoxetine plus placebo)NovartisApproved
✅pregabalin + PlaceboPfizerApproved
✅EscitalopramLundbeckApproved
✅Escitalopram + Placebo oral tabletLundbeckApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (4)

NCT IDPhaseStatus
NCT00660335Phase 3Completed
NCT00216294Phase 2Completed
NCT00036231Phase 3Terminated
NCT00036244Phase 3Completed

Competing Products

17 competing products in Obsessive Compulsive Disorder (OCD)

See all competitors
ProductCompanyStageHype Score
DuloxetineEli LillyApproved
43
Fluvoxamine maleate + PlaceboAbbViePhase 3
40
quetiapine fumarate + SSRI/ClomipramineAstraZenecaPhase 3
40
QuetiapineAstraZenecaPhase 2
35
Clomipramine (fluoxetine plus clomipramine) + Quetiapine (fluoxetine plus quetiapine) + Placebo (fluoxetine plus placebo)NovartisApproved
43
Bitopertin + Placebo + SSRIRochePhase 2
35
sertralinePfizerPre-clinical
26
pregabalin + PlaceboPfizerApproved
43
Sertraline + Levetiracetam + PlaceboUCBPhase 2/3
30
EscitalopramLundbeckApproved
36
Escitalopram + Placebo oral tabletLundbeckApproved
44
Valbenazine + PlaceboNeurocrine BiosciencesPhase 2
39
Troriluzole + PlaceboBiohavenPhase 3
34
Troriluzole + PlaceboBiohavenPhase 3
34
Troriluzole + PlaceboBiohavenPhase 2/3
32
Troriluzole (BHV-4157)BiohavenPhase 3
26
Nitrous Oxide + NitrogenBrain BiotechPhase 2
32